FGI-106

FGI-106
Legal status
Legal status
  • Investigational New Drug
Identifiers
CAS Number 501081-38-5 YesY
PubChem (CID) 432342
ChemSpider 382357
Chemical and physical data
Formula C28H38N6
Molar mass 458.640
3D model (Jmol) Interactive image

FGI-106 is a broad-spectrum antiviral drug developed as a potential treatment for enveloped RNA viruses, in particular viral hemorrhagic fevers from the bunyavirus, flavivirus and filovirus families. It acts as an inhibitor which blocks viral entry into host cells. In animal tests FGI-106 shows both prophylactic and curative action against a range of deadly viruses for which few existing treatments are available, including the bunyaviruses Hantavirus, Rift Valley fever virus and Crimean-Congo hemorrhagic fever virus, the flavivirus Dengue virus, and the filoviruses Ebola virus and Marburg virus.[1][2][3][4][5]

See also

References

  1. Aman, M. J.; Kinch, M. S.; Warfield, K.; Warren, T.; Yunus, A.; Enterlein, S.; Stavale, E.; Wang, P.; Chang, S.; Tang, Q. (2009). "Development of a broad-spectrum antiviral with activity against Ebola virus". Antiviral Research. 83 (3): 245–251. doi:10.1016/j.antiviral.2009.06.001.
  2. Kinch (2010). "Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae". Virus Adaptation and Treatment: 9. doi:10.2147/VAAT.S6903.
  3. Basu, A.; Li, B.; Mills, D. M.; Panchal, R. G.; Cardinale, S. C.; Butler, M. M.; Peet, N. P.; Majgier-Baranowska, H.; Williams, J. D.; Patel, I.; Moir, D. T.; Bavari, S.; Ray, R.; Farzan, M. R.; Rong, L.; Bowlin, T. L. (2011). "Identification of a Small-Molecule Entry Inhibitor for Filoviruses". Journal of Virology. 85 (7): 3106–3119. doi:10.1128/JVI.01456-10.
  4. Ippolito, G.; Feldmann, H.; Lanini, S.; Vairo, F.; Di Caro, A.; Capobianchi, M.; Nicastri, E. (2012). "Viral hemorrhagic fevers: Advancing the level of treatment". BMC Medicine. 10: 31. doi:10.1186/1741-7015-10-31. PMC 3325866Freely accessible. PMID 22458265.
  5. Picazo E, Giordanetto F. Small molecule inhibitors of ebola virus infection. Drug Discovery Today February 2015, 20(2):277–286. doi:10.1016/j.drudis.2014.12.010


This article is issued from Wikipedia - version of the 8/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.